Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans
sklademVydáno: 2015-01-20
PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans

PD IEC/TR 62471-3:2015

Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
290.07 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
29.01 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
87.02 €
Anglicky Hardcopy
In stock
290.07 €
Označení normy:PD IEC/TR 62471-3:2015
Počet stran:34
Vydáno:2015-01-20
ISBN:978 0 580 84356 3
Status:Standard
DESCRIPTION

PD IEC/TR 62471-3:2015


This standard PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems is classified in these ICS categories:
  • 31.260 Optoelectronics. Laser equipment
  • 29.140.01 Lamps in general

This part of IEC 62471, which is a technical report, provides guidelines for the safe use of INTENSE PULSED LIGHT (IPL) source equipment in professional premises.

This technical report sets out the control measures recommended for the safety of recipients of IPL treatment, staff, service, maintenance personnel and others. Engineering controls which form part of the IPL equipment or the installation are also briefly described to provide an understanding of the general principles of protection.

1.2 Object

The object of this report is to provide information which helps to protect persons from hazardous exposure to optical radiation and other associated hazards by providing guidance on how to establish safety measures and procedures.

NOTE Although the manufacturers provide treatment information in their instructions for use, such information may not be exhaustive or applicable to all CLIENT treatment conditions.

If IPLs are applied to patients in medical premises, the physician is deemed to be responsible for all medical aspects of the treatment including his or her decisions about questions of indication and contraindication such as found in Clauses 5 and 6.